EuroPCR is the Annual Meeting of the European Association of Percutaneous Cardiovascular Interventions focused at delivering the recent advancements in research related to Cardiology and scheduled to be held between between 22 – 25 May 2018.

Alvimedica has participated at EuroPCR which took place in Paris from the 22nd of May to the 25th of May, 2018.
 

Alvimedica booth: #F28 (Level 1-Hall Passy)
 
Alvimedica TNT Session:
 
Title: ‘Amphilimus™ eluting stent: leveraging on innovative technology to go beyond current PCI clinical boundaries in diabetic and high-bleeding risk patients’
 
Chairpersons: R. Mehran, S. Verheye
Panellists: R. Byrne, R. Romaguera, P. Stella, L. Timmers
 
Agenda:
12:15     Session objectives - S. Verheye
12:17     Rethinking DES technology to advance device efficacy and safety - R. Byrne
12:25     Amphilimus™ eluting stent - clinical results and ongoing clinical plan - R. Romaguera
12:33     Patient presentation - S. Verheye
12:35     Key objectives, strategy, tools and technique presented by Operators
12:37     LIVE case procedure from Clinique Pasteur, Toulouse
13:17     LIVE Time to React@PCR with Operators
13:27     PCI efficacy vs. bleeding - an interconnected equation - P. Stella
13:35     ReCre8 study - Recorded case from University hospital Utrecht - Utrecht, Netherlands - L. Timmers
14:03     Time to React@PCR
14:13     Session evaluation and key learnings - R. Mehran
  Download presentations here